Atossa Therapeutics Inc

Research Atossa Therapeutics Inc (ATOS) on Bullrun: market cap USD 17.05M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerATOS
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 17.05M
• Financial periodFY2025
• Net income-USD 34.77M
• Free cash flow-USD 29.79M

Valuation Snapshot

latest market cap is USD 17.05M.

About Atossa Therapeutics Inc

Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines in areas of significant unmet medical need in oncology in the United States. Its lead drug candidate is oral (Z)-endoxifen, a selective estrogen receptor modulator and selective estrogen receptor degrader currently in Phase 2 clinical development for the treatment and reduction of risk of breast cancer, as well as in other therapeutic areas. The company was formerly known as Atossa Genetics Inc.

Frequently asked questions

What is Atossa Therapeutics Inc's market cap?

Atossa Therapeutics Inc's market capitalization is USD 17.05M.

What does Atossa Therapeutics Inc do?

Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines in areas of significant unmet medical need in oncology in the United States.